|
The countdown clock is ticking on the status of federal funding and the end of the two-year suspension of the medical device tax. First payments on the medical device tax are due to be made in just 12 days.Continue reading
Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to its Board of Directors. Recently retired as Senior Vice President for Science Policy at the Biotechnology Innovation Organization (BIO), Ms. Holcombe brings to the Board her extensive experience in health care and regulatory policy, a history of collaboration with US regulatory agencies, and broad knowledge of government initiatives that affect the biotechnology and pharmaceutical industries.Continue reading
TUCSON, Ariz., Jan. 16, 2018 — HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced that it intends to offer and sell, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering.Continue reading
The Patient Safety Movement Foundation Board of Directors has selected RightBio Metrics technology as a finalist for the Patient Safety Innovation Awards. The third annual Patient Safety Innovation Awards have drawn in a plethora of innovative products and processes designed to significantly improve patient safety and help reach the foundation’s goal of ZERO preventable patient deaths by 2020. These submissions from across the globe represent some of the most innovative products and process improvements the Patient Safety Movement Foundation has seen in the last three years . There were more than 50 submissions and RightBio Metrics was selected as one of three finalists.Continue reading
AZ-HCIF is the first in a portfolio of endowments from across the U.S. and around the world that will be collectively grown and managed by the Healthcare Impact Foundation (HCIF).Continue reading
World-renowned researchers and science aficionados converge at valley restaurantsContinue reading
Amelia Gallitano, MD, PhD, a physician-scientist at the University of Arizona College of Medicine – Phoenix, has received a grant to develop a novel diagnostic test for schizophrenia.Continue reading
Arizona’s biotech community will be telling its story at the largest annual convergence of life science innovators and investors during JPM18.Continue reading